Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

Helios+ UV-C System

N.º K: K242604 · 2025-05-27

SolicitantePreventamed Technologies, Inc. Dba Surfacide Manufacturing
Fecha de decisión2025-05-27
Código de productoQXJ
Comité asesorHO
DecisiónSubstantially Equivalent

Resumen del dispositivo

Helios+ UV-C System is the device name listed in this FDA 510(k) record. The listed applicant is Preventamed Technologies, Inc. Dba Surfacide Manufacturing. It received FDA 510(k) clearance on 2025-05-27 under 510(k) number K242604. The device is classified under product code QXJ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Helios+ UV-C System?

Helios+ UV-C System is a medical device that received FDA 510(k) clearance on 2025-05-27. The listed applicant is Preventamed Technologies, Inc. Dba Surfacide Manufacturing. The 510(k) number is K242604.

When did Helios+ UV-C System receive FDA 510(k) clearance?

Helios+ UV-C System received FDA 510(k) clearance on 2025-05-27, under 510(k) number K242604.

Who is the listed applicant for Helios+ UV-C System?

The FDA 510(k) record lists Preventamed Technologies, Inc. Dba Surfacide Manufacturing as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Helios+ UV-C System?

The FDA product code for Helios+ UV-C System is QXJ.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑